U-M startup Kura Oncology goes public, raises $50 million

11/6/2015

La Jolla, California-based Kura Oncology Inc, a biopharmaceutical company focused on treating solid tumors and blood cancers, has raised $50 million for its IPO after pricing its 6.25 million shares at $8 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “KURA.” Citigroup and Leerink Partners are serving as lead underwriters. Kura Oncology’s backers included EcoR1 Capital, Fidelity Management & Research Company, ARCH Venture Partners, Tavistock Life Science’s Boxer Capital, Partner Fund Management and Nextech Invest…